RE:news is outTo me, I take this NR to indicate almost entirely that maybe now finally one of the big boy pharma companies could start to help push Ruvidar from a FDA standpoint. That might even be the sole purpose of this NR? Curious as to whether there's been any contact or collaboration with big pharma on this research, althogh if there was then I'd think Theralase would have gladly announced it (for street cred).
This is the kind of thing that in theory could make big pharma finally see dollar signs and finally want to partner. Whereas maybe previosly they were sitting back and saying hey this little co is floundering and is no threat to us so let's see if they go belly-up. It would be nice if this helps to change the perspective.